INFLAMMATIX, INC.
Sunnyvale, CA · Founded 2016 · CIK 0001801477 · Medtech · Private
MyRNA point-of-care instrument for quantifying blood mRNA biomarkers to diagnose acute myocardial infarction
inflammatix.com →- Grants
- $3.3M
- 5 awards
- Sector median: 1
- Raised
- $134M
- 2 Form D · Mar 2021
- 66 months since last filing
- Contracts
- $29M
- 3 awards · Health and Human S
- #33 of 4531 in medtech
- Patents
- 25
- 0 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Defense · Phase II · Point-of-care Monitoring of the Host-Pathogen Interaction during Infection | $999,923 | |
| Federal contract | Department of Health and Human Services · Inflammatix Host Response-based Diagnostic (hostdxtm-sepsis) | $510,000 | |
| Federal contract | Department of Health and Human Services · Development Of "a Full Stack Of Host-response Solutions To Infectious Disease Testing To Address Outpatient And Inpatient Testing For Acute Infections And Sepsis Both During And Outside Of Influenza Season" | $27,992,717 | |
| Private capital raised | Form D · SEC | $32,072,827 | |
| Federal grant | Department of Health and Human Services · Phase I · Development Of Baseline Gene Expression-based Response Predictor For Anti-tnfa Therapy In Patients With Inflammatory Bowel Diseases | $251,371 | |
| Private capital raised | Form D · SEC | $102,396,088 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes | $683,888 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes | $1,017,950 | |
| Federal contract | Department of Health and Human Services · Inflammatix, Inc. R&d For Triverity Cartridge Development Aoi #2 (infection Severity And Solving Sepsis) | $749,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a multi-RNA signature in blood towards a rapid diagnostic test to robustly distinguish patients with acute myocardial infarction | $299,762 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 30 | CRITICAL INNOVATIONS LLC | $33M | — |
| 31 | Outset Medical | $32M | $395M |
| 32 | NEUROWAVE SYSTEMS INC | $32M | — |
| 33 | INFLAMMATIX, INC. | $29M | $134M |
| 34 | FORT DEFIANCE INDUSTRIES LLC | $27M | — |
| 35 | QUANTUM APPLIED SCIENCE & RESEARCH INC | $25M | — |
| 36 | Itamar Medical | $24M | $15M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- KENNETH BAHKDirector
- JUSTIN KAODirector
- DAVID PERSINGDirector
- JONATHAN ROMANOWSKYExecutive Officer
- MICHAEL RUBINDirector
- TIMOTHY SWEENEYDirector · Executive Officer
- STEVEN TABLAKDirector
Patents
- Methods For Diagnosing Myocardial Infarctionapplication
- A Baseline Gene Expression-based Prognostic For Anti-tnf Alpha Therapy Response In Patients With Inflammatory Bowel Diseaseapplication
- Fluidic Methodsapplication
- Methods Of Diagnosis Of Respiratory Viral Infectionsapplication
- Fluidic Device And Methods For Characterization Of An Infection Or Other Conditionapplication
- Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasetsapplication
- Determining Mortality Risk Of Subjects With Viral Infectionsapplication
- Systems And Methods For Assessing A Bacterial Or Viral Status Of A Sampleapplication
- Assessing Host Rna Using Isothermal Amplification And Relative Abundanceapplication
- Fluidic Methodsapplication
- Isothermal Amplification-based Diagnosis And Treatment Of Acute Infectionapplication
- Methods Of Diagnosis Of Respiratory Viral Infectionsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.